To establish the clinical significance of SMYD5 and RPL40 K22me3, we analyzed 202 human HCC patient samples from a Zhongshan Hospital cohort (Shanghai), performing IHC examinations to quantify the abundance of SMYD5, RPL40, and RPL40 K22me3. This evidence concerns the gene SMYD5 and hepatocellular carcinoma.